Moreover, leptin improves metabolic abnormalities, including insulin resistance and hyperlipidemia, when administrated to lipoatrophic mice which have low levels of leptin due to the lack of subcutaneous adipose tissue (Shimomura et al. 1999). The gene discussed is LEP; the disease is hyperlipidemia.